CVS Health Corporation
CVS
$61.51
-$2.15-3.38%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 356.62B | 346.60B | 338.07B | 329.92B | 321.63B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 356.62B | 346.60B | 338.07B | 329.92B | 321.63B |
| Cost of Revenue | 303.35B | 293.40B | 284.97B | 276.44B | 267.97B |
| Gross Profit | 53.28B | 53.21B | 53.10B | 53.48B | 53.66B |
| SG&A Expenses | 39.25B | 38.88B | 38.71B | 38.18B | 37.92B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 342.59B | 332.27B | 323.68B | 314.61B | 305.89B |
| Operating Income | 14.03B | 14.33B | 14.39B | 15.30B | 15.74B |
| Income Before Tax | 11.17B | 11.62B | 4.16B | 5.71B | 5.84B |
| Income Tax Expenses | 2.81B | 2.97B | 1.17B | 1.60B | 1.51B |
| Earnings from Continuing Operations | 8.37K | 8.65K | 2.99K | 4.11K | 4.33K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -24.00M | -21.00M | -24.00M | -21.00M | -16.00M |
| Net Income | 8.34B | 8.63B | 2.97B | 4.09B | 4.31B |
| EBIT | 14.03B | 14.33B | 14.39B | 15.30B | 15.74B |
| EBITDA | 18.40B | 18.60B | 18.59B | 19.48B | 19.97B |
| EPS Basic | 6.49 | 6.69 | 2.34 | 3.16 | 3.29 |
| Normalized Basic EPS | 6.07 | 6.25 | 6.28 | 6.68 | 6.79 |
| EPS Diluted | 6.47 | 6.65 | 2.31 | 3.12 | 3.24 |
| Normalized Diluted EPS | 6.05 | 6.23 | 6.26 | 6.65 | 6.75 |
| Average Basic Shares Outstanding | 5.14B | 5.16B | 5.19B | 5.22B | 5.25B |
| Average Diluted Shares Outstanding | 5.16B | 5.19B | 5.21B | 5.25B | 5.28B |
| Dividend Per Share | 2.42 | 2.37 | 2.31 | 2.26 | 2.20 |
| Payout Ratio | 37.54% | 35.59% | 101.82% | 72.42% | 67.43% |
